Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Should lead to a good rise later.... thinking a 30p close is realistic.
ARB was phenomenal in its day and I did well in no time at all but look at it now... I now have a free ride but am so far under water with it its not funny and I see it going bust this year....
Completely different animal altogether.
FOMO? I'm still not sure, why it's gone up a bit this morning.
Exactly. Those are some cracking "facts" to remind us of why we are all invested in Sareum. The gains really can be stratospheric in this space, as we have already seen with Sareum and others in the past. We just require positive data now from Australia and the share price will react accordingly. ARB, in another sector, is another great example. 3p to 300p......
Good luck, Brighty
Buys v sells, why so many buy 😁
Good morning Lsesar.
Since we have been in discussions with interested parties, for what seems like an eternity, trial data would be shared with interested party.
Until.this data is known and confirmed very little can happen apart from very low ball offer.
My opinion for what it is worth is we will have absolutely no problems with daily doses up to 300mg.
Originally put as range from 12.5 mg to maximum of 1000 mg per person although therapeutic dosing giving mg per kg is the preferred means
Should we have a similar safety profile to Deucravacitinib with and increased efficacy in certain Indications, we will then not be tainted with black box warnings, it will leave us close to or at the top of auto immune inhibitor treatment.
In preclinical Sareum took SDC1801 to over 30 times treatment levels with no observed adverse effects.
Regards
@funnyguy. I think the number 25 on a roulette wheel is red, not black. If you even get that right there’s not much chance of your wisdom being taken seriously pal. Gla x
I haven’t got the heart to tell the poor guys over at MAST of their imminent funding agreement with Riverfort and how it’s likely to work out 🥲
Great Post Basil
And that's what us long term holders are patiently waiting for.
And that's a fact.
If two parts of the trials are complete and the data has been collected (Sad and Food-interaction) and were just waiting for the MAD trial to complete. Would the first two trial results be shared with partners? Wonder what has been discussed already ? If we get a positive report, what does that mean for our market capital valuation - yes it will be more but how much. Been trying to find Pharma who were in a similar stage to us with a similar pipeline and what their MC was at the end of P1 vs prior to P1 and what they eventually sold for.
Many on here – perhaps disrupters – don’t understand the gains that are often achieved in the pharma sector or don’t want you to know! For those that don’t know SAR has already had one amazing gain of x 45 from 0.2p to 9p (10p to 450p in post consolidation share price terms). That's a fact.
It was, perhaps, a false start but the rise was based on its lead candidate SDC-1801, the very same one that is in clinical trials in Oz. It is primed to lift off again now that RF are shortly going to be out of the mix and because SDC-1801 data is about to be unveiled.
You only have to see what happened to a similar bombed out share price with Tempest Therapeutics to see what’s possible. They had dropped to an all-time low (just like Sareum) and then positive data was revealed that saw the share price surge by x 39 in 1 week last September. That’s a fact.
Most of us will also know that a while back PYC went from 1p to 30p in 4 days. That’s a fact.
NCYT went rapidly from 12p to 1200p and Axsome Therapeutics climbed x 54 in one year and is up overall since 2018 by 2,635%. That’s a fact.
Big gains happen in the pharma sector. We know that because SAR has already gone up x 46 before. That’s a fact.
If the data is positive it will start the firing gun for big pharma to do a licencing deal. At that stage our share price will then rocket.
It's heartening to see someone full of the joys of life.
Enjoy your day.
And the sun is out, have a good one folks
Funnyguy,
Operational disadvantage?
Australian clinical trials far more efficient and cost effective than UK. Added bonus of tax advantages.
This in reality is advantageous as can be shown from around the 6 week application time to acceptance. 6 months later and the MHRA cannot even state what additional information they require.
With regards to the above, this has no effect whatsoever whether a drug will pass or fail its trial objective.
I did not see SO returning 737 but had a degree of concern with no development for a period of 18 months.
We have a new private company in the US for licence as released in the RNS. I bet you did not see that coming.
As for Riverfort finance, l must admit l did not see that coming along with its death spiral. Long term proper, positive investors took care of that with WRAP offer.
As for
'So, i tell you what let's reconvene when all the results are known and we know the next step, until then it's all conjecture. So regardless of your ability to copy and paste form medical journals what have you got?'
So you admit to it all being conjecture yet cannot see your blinding error with regards to posting waiting for confirmation of failed test for Sareum.
On top of the copy and paste medical journals, l do understand them to a great extent. I have spent 1000's of hours researching.
I expect good results on what l know. Preclinical trial was carried out with attention to detail. Reports given by qualified scientists!
On the other hand we have you.
You already see failure as clearly you do not know even when the outcome is not known.
Regards
Regards
I said people who invest on seeing SAR on the top riser board deserve to lose money.
Operationally disadvantage ie SAR had to set up an entity in Australia so extra expense, other side of the world
MRHA turned it down that's why we are in Australia you fool.
the rest is all about opinion. Sierra dropping and returning 737, did you see that coming. Did you see Riverfort finance coming, no you did not. It's all opinion. You talk as if we are playing roulette, but you know it will land on black 25 and its just timing. The only success of SAR in the last few years is the testing going on in Australia and we got there by default. So, i tell you what let's reconvene when all the results are known and we know the next step, until then it's all conjecture. So regardless of your ability to copy and paste form medical journals what have you got?
Funnyguy.
Your claimed 'tuppence worth' after reading is not worth anywhere near that.
What you have based your statement on has absolutely nothing to do with a kinase inhibitors safety or efficacy.
What l will say is that SDC1801 in preclinical was tested to over 30 times therapeutic dose with no adverse effects encountered.
Efficacy in vitro and in vivo were reported good
This information readily available by qualified scientists and you think you know better than them
Knowledge is power and clearly you have very little of either.
Regards
Funnyguy it is not opinion when you post
'We are not too far away from confirmation that Sareum have failed the tests and will not pursue.'
The above implies known reported failure,
You are nothing more than a little liar.
MHRA has nothing to do with testing you imbecile.
To go to Australia for testing at huge disadvantage operationally to Sar.
Where has a statement been made either expressed or implied that their is any operational disadvantage here?
As for the result?
Based on your ' confirmation that Sareum have failed the tests and will not pursue'
You don't know yet deliberately put up misleading information.
As for asking you on what factual material you base such a statement you fail to give a satisfactory answer.
I did not ask where those that opinionated flying through trials or close to a licensing deal gain their information. I asked YOU, where you get your evidence.
There is no evidence to suggest that. It has sweet FA to do with MHRA going to Australia or anything.
Now educate yourself sonny and don't post opinion as a statement unless you can clearly back it up.
You have failed abysmally to get anywhere near a fraction of a satisfactory reply.
Being here, as you claim for over 10 years it is readily apparent you know very little. You certainly have not been on this LSE chatboard as Funnyguy for 10 years
One more thing sonny I do not look at the leader board to chose who or what l invest in.
As for deserving to lose money? I don't think people making investments whether they go long or short deserve to lose money.
Clearly you have a big chip on your shoulder, you have already sold out here at a small loss as stated by yourself.
Clearly my investment strategy is different to yours.
Regards
Sad old git, i have been here in excess 10 years. I have invested, disinvested and recently i am trading and made some money. If results do prove to be good then i will invest not trade
Meant to say deserve to lose any money invested. People who invest based on top risers is not a good strategy
The same info others have about it flying though its trials and we are close to licensing deal. its opinion
but let's just say i base it on
1- MRHA UK rejecting
2- had to go to Australia- the other side of the world to carry out testing at huge disadvantage operationally to SAR
3- Have still to deliver result
4- hug problem with finance and funding so had to use Riverfort
thats my tuppence worth
The reason it sticks in my head is due to the BRH reference. Braveheart. I’ve literally NEVER seen anyone else reference that.
Liked the film.
Crap share.
Well said Celtic007.
The thing is, the derampers cannot get their tiny little brains around the fact that when one times their entry well, time after time, it gives huge scope to make HUGE money.
My largest tranche was in 2015 at 0.0185p. I had circa 0.25% of the company, prior to the recent dilution, on a pretty-much free carry. I took part in the WRAP. I bought on the open market etc in the last month or so at anything between 10-14p. I added almost 250k shares. If Sareum went up in a puff of smoke tomorrow, I’ve still won. Simples.
The ‘derampers’ don’t have the balls to short (though I believe MAJ/Puma/Robin Hood did but it was evidently account spoofing). I have asked a boring troll that dedicates its pathetic life to trolling another backwater forum to provide screenshots of its fictitious shorts. Guess how many times it has done? NEVER. Yet it comes on the boards gloating if it drops 0.10%!?! Yet it never makes a penny. Not a solitary square root of f*** all.
Oh, I believe ‘nicely’ is that clueless moron Trimme, who bought on a peak with no grasp of risk/reward then tried to tell those of us that bought low and early (same again with the WRAP) that we were wrong!?! 😂 No concept that tge risk/reward profile is entirely different on the same share due to one’s entry price. Basically, to be up polite, a complete moron.
Funnyguy,
Not sure what you mean by 'deserve any money invested'
I have been here since Aug 2012.
A long journey yes, even longer than l thought.
Companies have their ups and downs. These ups and downs do not change what the company has.
I believe in what they have created.
As you have no belief in what the company has created as indicated by your posting history, then what on heavens name prompted you to invest?
Regards
Funnyguy.
Opinion is one thing misleading or false information is something else.
This stated by you a few days back, can you confirm this is correct?
'We are not too far away from confirmation that Sareum have failed the tests and will not pursue.
On what factual data or statements have you based your above post, to give any credibility?
Correct me if l am wrong that if you have no such information to rely on, as l believe, then you have posted misleading information but also false information.
Regards
I meant to say, you deserve any money you have "invested " in SAR if you only know about it because you saw it on top risers board
For the record, i think another 10-15% drop tomorrow